IP Verse

Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors - EP2432454

EP2432454

NEURODERM
Application Number
EP10725880A
Filing Date
May 17, 2010
Status
Opposition Rejected
Dec 6, 2019
Grant Date
Mar 1, 2017
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2432454B1 was granted to Neuroderm on Mar 1, 2017 following the initial filing on May 17, 2010 under the application number EP10725880A . The current legal status of the patent is Opposition Rejected.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSNov 29, 2017ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents